Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review.

Göbel K, Eichler S, Wiendl H, Chavakis T, Kleinschnitz C, Meuth SG.

Front Immunol. 2018 Jul 26;9:1731. doi: 10.3389/fimmu.2018.01731. eCollection 2018.

2.

Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging.

Seitz CB, Droby A, Zaubitzer L, Krämer J, Paradis M, Klotz L, Wiendl H, Groppa S, Meuth SG, Zipp F, Fleischer V.

J Neurol. 2018 Aug 2. doi: 10.1007/s00415-018-8988-3. [Epub ahead of print]

PMID:
30073502
3.

Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.

Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L.

Front Immunol. 2018 Jul 9;9:1560. doi: 10.3389/fimmu.2018.01560. eCollection 2018.

4.

Impairment of frequency-specific responses associated with altered electrical activity patterns in auditory thalamus following focal and general demyelination.

Narayanan V, Cerina M, Göbel K, Meuth P, Herrmann AM, Fernandez-Orth J, Stangel M, Gudi V, Skripuletz T, Daldrup T, Lesting J, Schiffler P, Wiendl H, Seidenbecher T, Meuth SG, Budde T, Pape HC.

Exp Neurol. 2018 Jul 23;309:54-66. doi: 10.1016/j.expneurol.2018.07.010. [Epub ahead of print]

PMID:
30048715
5.

Primary angiitis of the central nervous system: diagnosis and treatment.

Beuker C, Schmidt A, Strunk D, Sporns PB, Wiendl H, Meuth SG, Minnerup J.

Ther Adv Neurol Disord. 2018 Jul 9;11:1756286418785071. doi: 10.1177/1756286418785071. eCollection 2018. Review.

6.

Apraxia profiles-A single cognitive marker to discriminate all variants of frontotemporal lobar degeneration and Alzheimer's disease.

Johnen A, Reul S, Wiendl H, Meuth SG, Duning T.

Alzheimers Dement (Amst). 2018 May 16;10:363-371. doi: 10.1016/j.dadm.2018.04.002. eCollection 2018.

7.

Onconeural antigen spreading in paraneoplastic neurological disease due to small cell lung cancer.

Dik A, Strippel C, Mönig C, Golombeck KS, Schulte-Mecklenbeck A, Wiendl H, Meuth SG, Johnen A, Gross CC, Melzer N.

Oxf Med Case Reports. 2018 Jul 9;2018(7):omy034. doi: 10.1093/omcr/omy034. eCollection 2018 Jul.

8.

Immune cell profiling in the cerebrospinal fluid of patients with primary angiitis of the central nervous system reflects the heterogeneity of the disease.

Strunk D, Schulte-Mecklenbeck A, Golombeck KS, Meyer Zu Hörste G, Melzer N, Beuker C, Schmidt A, Wiendl H, Meuth SG, Gross CC, Minnerup J.

J Neuroimmunol. 2018 Aug 15;321:109-116. doi: 10.1016/j.jneuroim.2018.06.004. Epub 2018 Jun 7.

PMID:
29957380
9.

Amygdala enlargement and emotional responses in (autoimmune) temporal lobe epilepsy.

Holtmann O, Schlossmacher I, Moenig C, Johnen A, Rutter LM, Tenberge JG, Schiffler P, Everding J, Golombeck KS, Strippel C, Dik A, Schwindt W, Wiendl H, Meuth SG, Bruchmann M, Melzer N, Straube T.

Sci Rep. 2018 Jun 22;8(1):9561. doi: 10.1038/s41598-018-27914-z.

10.

Cerebrospinal Fluid Concentrations of Neuronal Proteins Are Reduced in Primary Angiitis of the Central Nervous System.

Ruland T, Wolbert J, Gottschalk MG, König S, Schulte-Mecklenbeck A, Minnerup J, Meuth SG, Groß CC, Wiendl H, Meyer Zu Hörste G.

Front Neurol. 2018 Jun 5;9:407. doi: 10.3389/fneur.2018.00407. eCollection 2018.

11.

A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation.

Thomas C, Zühlsdorf A, Hörtnagel K, Mulahasanovic L, Grauer OM, Kümpers P, Wiendl H, Meuth SG.

Front Neurol. 2018 May 25;9:383. doi: 10.3389/fneur.2018.00383. eCollection 2018.

12.

Reliability and main findings of the flexible endoscopic evaluation of swallowing-Tensilon test in patients with myasthenia gravis and dysphagia.

Im S, Suntrup-Krueger S, Colbow S, Sauer S, Claus I, Meuth SG, Dziewas R, Warnecke T.

Eur J Neurol. 2018 May 26. doi: 10.1111/ene.13688. [Epub ahead of print]

PMID:
29802670
13.

A Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.

Sauter RJ, Sauter M, Reis ES, Emschermann FN, Nording H, Ebenhöch S, Kraft P, Münzer P, Mauler M, Rheinlaender J, Madlung J, Edlich F, Schäffer TE, Meuth SG, Düerschmied D, Geisler T, Borst O, Gawaz M, Kleinschnitz C, Lambris JD, Langer HF.

Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.034600. doi: 10.1161/CIRCULATIONAHA.118.034600. [Epub ahead of print]

PMID:
29802205
14.

Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review.

Dreikorn M, Milacic Z, Pavlovic V, Meuth SG, Kleinschnitz C, Kraft P.

Ther Adv Neurol Disord. 2018 Apr 20;11:1756286418770626. doi: 10.1177/1756286418770626. eCollection 2018. Review.

15.

Protective potential of dimethyl fumarate in a mouse model of thalamocortical demyelination.

Cerina M, Narayanan V, Delank A, Meuth P, Graebenitz S, Göbel K, Herrmann AM, Albrecht S, Daldrup T, Seidenbecher T, Gorji A, Kuhlmann T, Wiendl H, Kleinschnitz C, Speckmann EJ, Pape HC, Meuth SG, Budde T.

Brain Struct Funct. 2018 May 9. doi: 10.1007/s00429-018-1680-7. [Epub ahead of print]

PMID:
29744572
16.

The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review.

Marziniak M, Brichetto G, Feys P, Meyding-Lamadé U, Vernon K, Meuth SG.

JMIR Rehabil Assist Technol. 2018 Apr 24;5(1):e5. doi: 10.2196/rehab.7805.

17.

Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.

Krämer J, Lueg G, Schiffler P, Vrachimis A, Weckesser M, Wenning C, Pawlowski M, Johnen A, Teuber A, Wersching H, Meuth SG, Duning T.

J Alzheimers Dis. 2018;63(1):239-253. doi: 10.3233/JAD-170224.

PMID:
29614640
18.

Advances in Multiple Sclerosis 2017.

Göbel K, Kleinschnitz C, Meuth SG.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E901. doi: 10.3390/ijms19030901.

19.

Skeletal muscle cells actively shape (auto)immune responses.

Afzali AM, Müntefering T, Wiendl H, Meuth SG, Ruck T.

Autoimmun Rev. 2018 May;17(5):518-529. doi: 10.1016/j.autrev.2017.12.005. Epub 2018 Mar 9. Review.

PMID:
29526638
20.

[Cladribine tablets : Oral immunotherapy of relapsing-remitting multiple sclerosis with short yearly treatment periods].

Meuth SG, Ruck T, Aktas O, Hartung HP.

Nervenarzt. 2018 Aug;89(8):895-907. doi: 10.1007/s00115-018-0498-0. Review. German.

PMID:
29523912
21.

Cytokine signaling in multiple sclerosis: Lost in translation.

Göbel K, Ruck T, Meuth SG.

Mult Scler. 2018 Apr;24(4):432-439. doi: 10.1177/1352458518763094. Epub 2018 Mar 7.

PMID:
29512406
22.

Treatment choices and neuropsychological symptoms of a large cohort of early MS.

von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, Weber F, Linker RA, Ziemann U, Zettl UK, Zipp F, Wiendl H, Hemmer B, Gold R, Salmen A.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 1;5(3):e446. doi: 10.1212/NXI.0000000000000446. eCollection 2018 May.

23.

[Coagulation factors and multiple sclerosis : Key factors in the pathogenesis?]

Göbel K, Kleinschnitz C, Meuth SG.

Nervenarzt. 2018 Aug;89(8):908-912. doi: 10.1007/s00115-018-0491-7. Review. German.

PMID:
29404650
24.

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study.

Riepl E, Pfeuffer S, Ruck T, Lohmann H, Wiendl H, Meuth SG, Johnen A.

Front Neurol. 2018 Jan 16;8:730. doi: 10.3389/fneur.2017.00730. eCollection 2017.

25.

Defining response profiles after alemtuzumab: Rare paradoxical disease exacerbation.

Wiendl H, Calabresi PA, Meuth SG.

Neurology. 2018 Feb 13;90(7):309-311. doi: 10.1212/WNL.0000000000004969. Epub 2018 Jan 19. No abstract available.

PMID:
29352097
26.

Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis.

Kroth J, Ciolac D, Fleischer V, Koirala N, Krämer J, Muthuraman M, Luessi F, Bittner S, Gonzalez-Escamilla G, Zipp F, Meuth SG, Groppa S.

Mult Scler. 2017 Dec 1:1352458517748474. doi: 10.1177/1352458517748474. [Epub ahead of print]

PMID:
29226779
27.

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody.

Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N.

Ann Clin Transl Neurol. 2017 Oct 3;4(11):768-783. doi: 10.1002/acn3.444. eCollection 2017 Nov.

28.

Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia.

Pawlowski M, Lueg G, Gross CC, Johnen A, Krämer J, Weckesser M, Wiendl H, Meuth SG, Duning T.

Neurobiol Aging. 2018 Feb;62:45-52. doi: 10.1016/j.neurobiolaging.2017.09.032. Epub 2017 Oct 13.

PMID:
29107846
29.

NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage.

Casas AI, Geuss E, Kleikers PWM, Mencl S, Herrmann AM, Buendia I, Egea J, Meuth SG, Lopez MG, Kleinschnitz C, Schmidt HHHW.

Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12315-12320. doi: 10.1073/pnas.1705034114. Epub 2017 Oct 31.

30.

[New aspects of symptomatic MS treatment: Part 5 - fatigue].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Apr;89(4):446-452. doi: 10.1007/s00115-017-0442-8. Review. German.

PMID:
29079869
31.

[New aspects of symptomatic MS treatment: Part 6 - cognitive dysfunction and rehabilitation].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Apr;89(4):453-459. doi: 10.1007/s00115-017-0443-7. Review. German.

PMID:
29079868
32.

[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Feb;89(2):193-197. doi: 10.1007/s00115-017-0441-9. Review. German.

PMID:
29079866
33.

[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Feb;89(2):184-192. doi: 10.1007/s00115-017-0440-x. Review. German.

PMID:
29079865
34.

[What is new in symptomatic MS treatment: Part 1-introduction and methodical approach, ataxia and tremor].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2017 Dec;88(12):1421-1427. doi: 10.1007/s00115-017-0438-4. Review. German.

PMID:
29063261
35.

[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2017 Dec;88(12):1428-1434. doi: 10.1007/s00115-017-0439-3. Review. German.

PMID:
29063259
36.

Increase of Substance P Concentration in Saliva after Pharyngeal Electrical Stimulation in Severely Dysphagic Stroke Patients - an Indicator of Decannulation Success?

Muhle P, Suntrup-Krueger S, Bittner S, Ruck T, Claus I, Marian T, Schröder JB, Minnerup J, Warnecke T, Meuth SG, Dziewas R.

Neurosignals. 2017;25(1):74-87. doi: 10.1159/000482002. Epub 2017 Oct 17.

37.

An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Function.

Kleffner I, Eichler S, Ruck T, Schüngel L, Pfeuffer S, Polzer P, Dittrich R, Dziewas R, Gross CC, Göbel K, Wiendl H, Kehrel BE, Meuth SG.

Front Neurol. 2017 Sep 28;8:517. doi: 10.3389/fneur.2017.00517. eCollection 2017.

38.

Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis.

Merker M, Eichler S, Herrmann AM, Wiendl H, Kleinschnitz C, Göbel K, Meuth SG.

J Neuroimmunol. 2017 Dec 15;313:125-128. doi: 10.1016/j.jneuroim.2017.08.013. Epub 2017 Sep 21.

PMID:
28992973
39.

Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis.

Johnen A, Landmeyer NC, Bürkner PC, Wiendl H, Meuth SG, Holling H.

Neurosci Biobehav Rev. 2017 Dec;83:568-578. doi: 10.1016/j.neubiorev.2017.09.005. Epub 2017 Sep 8. Review.

PMID:
28890199
40.

Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.

Kovac S, Dinkova Kostova AT, Herrmann AM, Melzer N, Meuth SG, Gorji A.

Int J Mol Sci. 2017 Sep 8;18(9). pii: E1935. doi: 10.3390/ijms18091935. Review.

41.

TRPC6 channels modulate the response of pancreatic stellate cells to hypoxia.

Nielsen N, Kondratska K, Ruck T, Hild B, Kovalenko I, Schimmelpfennig S, Welzig J, Sargin S, Lindemann O, Christian S, Meuth SG, Prevarskaya N, Schwab A.

Pflugers Arch. 2017 Dec;469(12):1567-1577. doi: 10.1007/s00424-017-2057-0. Epub 2017 Aug 28.

PMID:
28849300
42.

Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters.

Schwab N, Schneider-Hohendorf T, Hoyt T, Gross CC, Meuth SG, Klotz L, Foley JF, Wiendl H.

Mult Scler. 2018 Apr;24(5):563-573. doi: 10.1177/1352458517728814. Epub 2017 Aug 29.

PMID:
28847222
43.

Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA.

Aulova KS, Toporkova LB, Lopatnikova JA, Alshevskaya AA, Sennikov SV, Buneva VN, Budde T, Meuth SG, Popova NA, Orlovskaya IA, Nevinsky GA.

J Cell Mol Med. 2017 Dec;21(12):3795-3809. doi: 10.1111/jcmm.13289. Epub 2017 Aug 5.

44.

Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample.

Gaissmaier W, Giese H, Galesic M, Garcia-Retamero R, Kasper J, Kleiter I, Meuth SG, Köpke S, Heesen C.

Patient Educ Couns. 2018 Jan;101(1):74-78. doi: 10.1016/j.pec.2017.07.018. Epub 2017 Jul 17.

PMID:
28764895
45.

Cortex Parcellation Associated Whole White Matter Parcellation in Individual Subjects.

Schiffler P, Tenberge JG, Wiendl H, Meuth SG.

Front Hum Neurosci. 2017 Jul 6;11:352. doi: 10.3389/fnhum.2017.00352. eCollection 2017.

46.

Acetylcholine-dependent upregulation of TASK-1 channels in thalamic interneurons by a smooth muscle-like signalling pathway.

Leist M, Rinné S, Datunashvili M, Aissaoui A, Pape HC, Decher N, Meuth SG, Budde T.

J Physiol. 2017 Sep 1;595(17):5875-5893. doi: 10.1113/JP274527. Epub 2017 Aug 3.

PMID:
28714121
47.

Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside.

Pawlowski M, Meuth SG, Duning T.

Diagnostics (Basel). 2017 Jul 13;7(3). pii: E42. doi: 10.3390/diagnostics7030042. Review.

48.

Treating refractory post-herpetic anti-N-methyl-d-aspartate receptor encephalitis with rituximab.

Strippel C, Mönig C, Golombeck KS, Dik A, Bönte K, Kovac S, Schulte-Mecklenbeck A, Wiendl H, Meuth SG, Johnen A, Gross CC, Melzer N.

Oxf Med Case Reports. 2017 Jul 3;2017(7):omx034. doi: 10.1093/omcr/omx034. eCollection 2017 Jul.

49.

Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease.

Ruland C, Renken H, Kuzmanov I, Fattahi Mehr A, Schwarte K, Cerina M, Herrmann A, Otte DM, Zimmer A, Schwab N, Meuth SG, Arolt V, Klotz L, Förster I, Scheu S, Alferink J.

Brain Behav Immun. 2017 Nov;66:382-393. doi: 10.1016/j.bbi.2017.06.010. Epub 2017 Jun 19.

PMID:
28642092
50.

Apoptosis Following Cortical Spreading Depression in Juvenile Rats.

Jahanbazi Jahan-Abad A, Alizadeh L, Sahab Negah S, Barati P, Khaleghi Ghadiri M, Meuth SG, Kovac S, Gorji A.

Mol Neurobiol. 2018 May;55(5):4225-4239. doi: 10.1007/s12035-017-0642-z. Epub 2017 Jun 13.

PMID:
28612259

Supplemental Content

Loading ...
Support Center